FDA Issues Warning Letters to Two Clinical Investigators

Oops! Subscribers must be logged in to access this content.

Not A Thompson FDA Subscriber?

Unlock access to the benefits below with a no-cost, risk-free trial of the FDA Compliance Expert Suite.

Subscription Benefits

Start Your Free Trial

By signing up for a tour of the Thompson FDA Compliance Expert Suite, you are also registering to receive email offers and product updates from us. Simply click unsubscribe at the bottom of any email if you would like to discontinue delivery.

FDA Issues Warning Letters to Two Clinical Investigators

J.W. Schomisch

June 11, 2023 at 05:04 PM EST

The FDA recently sent Warning Letters to two clinical investigators. Dr. Mobeen Mazhar, M.D., a clinical investigator in Houston, received a May 31 Warning Letter from the Center for Drug Evaluation and Research alleging the investigator failed to obtain informed consent or follow the investigational plan. In addition, Dr. Randy J. Epstein, the Chief Executive Officer of Chi... Read More

My Research Folders

You are not Logged in yet, Please login to see Your research folders.

Oops! Subscribers must be logged in to access this content.

Not A Thompson FDA Subscriber?

Unlock access to the benefits below with a no-cost, risk-free trial of the FDA Compliance Expert Suite.

Subscription Benefits

Start Your Free Trial

FDA Issues Warning Letters to Two Clinical Investigators

My Research Folders

THOMPSON FDA

COMPLIANCE EXPERT

RESOURCES

HELP

CONTACT